Irena Klima

801 total citations
17 papers, 485 citations indexed

About

Irena Klima is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Irena Klima has authored 17 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Irena Klima's work include Prostate Cancer Treatment and Research (9 papers), Cancer, Lipids, and Metabolism (4 papers) and Bone health and treatments (3 papers). Irena Klima is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Cancer, Lipids, and Metabolism (4 papers) and Bone health and treatments (3 papers). Irena Klima collaborates with scholars based in Switzerland, Netherlands and United States. Irena Klima's co-authors include George N. Thalmann, U. Studer, Regula Markwalder, Jeffrey Kiefer, Mary C. Farach‐Carson, Leland W.K. Chung, Robert E. Devoll, Robert A. Sikes, Marianna Kruithof‐de Julio and Sofia Karkampouna and has published in prestigious journals such as Nature Communications, Oncogene and The Journal of Urology.

In The Last Decade

Irena Klima

16 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Irena Klima Switzerland	11	233	157	140	125	114	17	485
Koviljka Matušan‐Ilijaš Croatia	12	210 0.9×	82 0.5×	100 0.7×	132 1.1×	117 1.0×	21	361
Carsten Haeckel Germany	14	168 0.7×	154 1.0×	97 0.7×	131 1.0×	133 1.2×	20	446
Teruyoshi Ue Japan	7	317 1.4×	262 1.7×	152 1.1×	96 0.8×	71 0.6×	8	603
Xuebing Di China	13	355 1.5×	197 1.3×	77 0.6×	226 1.8×	175 1.5×	24	700
R. Donnellan South Africa	7	302 1.3×	308 2.0×	54 0.4×	106 0.8×	92 0.8×	12	576
Sébastien de Feraudy United States	13	277 1.2×	174 1.1×	175 1.3×	113 0.9×	96 0.8×	32	655
Ahmed Guweidhi Germany	9	301 1.3×	304 1.9×	98 0.7×	104 0.8×	43 0.4×	12	643
Jingnan Shen China	13	150 0.6×	93 0.6×	100 0.7×	50 0.4×	149 1.3×	29	449
Jen-Wei Tsai Taiwan	13	283 1.2×	184 1.2×	71 0.5×	110 0.9×	251 2.2×	13	588
Zahida Saad Canada	8	194 0.8×	220 1.4×	188 1.3×	121 1.0×	27 0.2×	11	456

Countries citing papers authored by Irena Klima

Since Specialization

Citations

This map shows the geographic impact of Irena Klima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irena Klima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irena Klima more than expected).

Fields of papers citing papers by Irena Klima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irena Klima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irena Klima. The network helps show where Irena Klima may publish in the future.

Co-authorship network of co-authors of Irena Klima

This figure shows the co-authorship network connecting the top 25 collaborators of Irena Klima. A scholar is included among the top collaborators of Irena Klima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irena Klima. Irena Klima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Brot, Simone de, Eugenio Zoni, Antonella Brunello, et al.. (2024). CRIPTO’s multifaceted role in driving aggressive prostate cancer unveiled by in vivo, organoid, and patient data. Oncogene. 44(7). 462–475. 3 indexed citations

2.

Kiener, Mirjam, Tarcisio Fedrizzi, Federico La Manna, et al.. (2023). Bladder cancer organoids as a functional system to model different disease stages and therapy response. Nature Communications. 14(1). 2214–2214. 49 indexed citations

3.

Özdemir, Berna C., Nicolas Arnold, Achim Fleischmann, et al.. (2022). Prediction of Biochemical Recurrence Based on Molecular Detection of Lymph Node Metastasis After Radical Prostatectomy. European Urology Open Science. 44. 1–10. 1 indexed citations

4.

Karkampouna, Sofia, Maria De Filippo, Charlotte K.Y. Ng, et al.. (2020). Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures. Cancers. 12(12). 3786–3786. 13 indexed citations

5.

Manna, Federico La, Marta De Menna, Nikhil Patel, et al.. (2020). Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity. Frontiers in Oncology. 10. 1012–1012. 32 indexed citations

6.

Zoni, Eugenio, Charlotte K.Y. Ng, Salvatore Piscuoglio, et al.. (2019). Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer. Molecular Cancer Research. 17(5). 1049–1062. 21 indexed citations

7.

Kiener, Mirjam, Markus Krebs, Joël Grosjean, et al.. (2019). miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo. BMC Cancer. 19(1). 627–627. 40 indexed citations

8.

Karkampouna, Sofia, Danny van der Helm, Peter C. Gray, et al.. (2018). CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma. The Journal of Pathology. 245(3). 297–310. 26 indexed citations

9.

Zoni, Eugenio, Sofia Karkampouna, Peter C. Gray, et al.. (2017). ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models. Frontiers in Cell and Developmental Biology. 5. 104–104. 4 indexed citations

10.

Peternac, Daniel, Irena Klima, Marco Cecchini, et al.. (2008). Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression. The Prostate. 68(12). 1307–1318. 15 indexed citations

11.

Peternac, Daniel, Irena Klima, Marco Cecchini, Urs E. Studer, & George N. Thalmann. (2006). Prostate Specific Antigen Expression Does Not Necessarily Correlate With Prostate Cancer Cell Growth. The Journal of Urology. 176(1). 354–360. 5 indexed citations

12.

Bisoffi, Marco, Irena Klima, Ekaterina Gresko, et al.. (2004). EXPRESSION PROFILES OF ANDROGEN INDEPENDENT BONE METASTATIC PROSTATE CANCER CELLS INDICATE UP-REGULATION OF THE PUTATIVE SERINE-THREONINE KINASE GS3955. The Journal of Urology. 172(3). 1145–1150. 12 indexed citations

13.

Adsan, Öztüğ, Marco Cecchini, Marco Bisoffi, et al.. (2002). Can the reverse transcriptase‐polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen improve staging and predict biochemical recurrence?. British Journal of Urology. 90(6). 579–585. 10 indexed citations

14.

Bisoffi, Marco, Antoinette Wetterwald, Irena Klima, et al.. (2002). Scavenger receptor block as strategy for the identification of bone marrow homing phages by panning in vivo random peptide phage displayed libraries. Journal of Immunological Methods. 264(1-2). 173–186. 8 indexed citations

15.

Thalmann, George N., Robert A. Sikes, Robert E. Devoll, et al.. (1999). Osteopontin: possible role in prostate cancer progression.. PubMed. 5(8). 2271–7. 224 indexed citations

16.

Markwalder, Regula, Martin F. Fey, Irena Klima, et al.. (1997). Abnormal p53 expression is rare in clinically localized human prostate cancer: Comparison between immunohistochemical and molecular detection of p53 mutations. The Prostate. 31(4). 209–215. 22 indexed citations

17.

Markwalder, Regula, Martin F. Fey, Irena Klima, et al.. (1997). Abnormal p53 expression is rare in clinically localized human prostate cancer: Comparison between immunohistochemical and molecular detection of p53 mutations. The Prostate. 31(4). 209–215.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact